Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Elevation Oncology stock
Learn how to easily invest in Elevation Oncology stock.
Elevation Oncology is a biotechnology business based in the US. Elevation Oncology shares (ELEV) are listed on the NASDAQ and all prices are listed in US Dollars. Elevation Oncology employs 48 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Elevation Oncology stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ELEV. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Elevation Oncology stock price (NASDAQ: ELEV)Use our graph to track the performance of ELEV stocks over time.
Elevation Oncology shares at a glance
|Latest market close||$1.03|
|52-week range||$0.72 - $5.20|
|50-day moving average||$0.97|
|200-day moving average||$1.52|
|Wall St. target price||$4.17|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$6.72|
Buy Elevation Oncology stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Elevation Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Elevation Oncology price performance over time
|1 week (2023-01-26)||-0.96%|
|1 month (2022-12-30)||8.42%|
|3 months (2022-11-02)||-11.21%|
|6 months (2022-08-02)||-8.04%|
|1 year (2022-02-02)||-75.93%|
|2 years (2021-01-29)||N/A|
|3 years (2020-01-29)||N/A|
|5 years (2018-01-29)||N/A|
Is Elevation Oncology stock undervalued or overvalued?
Valuing Elevation Oncology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elevation Oncology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Elevation Oncology's P/E ratio
Elevation Oncology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Elevation Oncology shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Elevation Oncology's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.
Elevation Oncology financials
|Gross profit TTM||$0|
|Return on assets TTM||-39.65%|
|Return on equity TTM||-79.04%|
|Market capitalisation||$23.8 million|
TTM: trailing 12 months
Elevation Oncology share dividends
We're not expecting Elevation Oncology to pay a dividend over the next 12 months.
Elevation Oncology overview
Elevation Oncology, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York. .
Frequently asked questionsWhat percentage of Elevation Oncology is owned by insiders or institutions?
Currently 2.184% of Elevation Oncology shares are held by insiders and 71.101% by institutions. How many people work for Elevation Oncology?
Latest data suggests 48 work at Elevation Oncology. When does the fiscal year end for Elevation Oncology?
Elevation Oncology's fiscal year ends in December. Where is Elevation Oncology based?
Elevation Oncology's address is: 888 Seventh Avenue, New York, NY, United States, 10106 What is Elevation Oncology's ISIN number?
Elevation Oncology's international securities identification number is: US28623U1016
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert